Yvonne Greenstreet, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 7,727 shares at $245.26 ($1.9M) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Open-market sale of $1.9M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $242.37 | 1,068 | $259K | 13.7% |
| 2 | $242.37 | 1,068 | $259K | 13.7% |
| 3 | $243.36 | 1,173 | $285K | 15.2% |
| 4 | $243.36 | 1,173 | $285K | 15.2% |
| 5 | $244.41 | 791 | $193K | 10.3% |
| 6 | $244.41 | 791 |
| $193K |
| 10.3% |
| 7 | $245.26 | 580 | $142K | 7.6% |
| 8 | $245.26 | 580 | $142K | 7.6% |
| 9 | $246.18 | 238 | $59K | 3.1% |
| 10 | $246.18 | 238 | $59K | 3.1% |
| 11 | $247.35 | 23 | $6K | 0.3% |
| 12 | $248.36 | 4 | $993 | 0.1% |
| Total | $243.77 avg | 7,727 | $1.9M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $2.2M | — | Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |